SK Bioscience Co Ltd (302440)

Currency in KRW
45,450
-600(-1.30%)
Closed·
302440 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
302440 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
45,40046,200
52 wk Range
35,80061,500
Key Statistics
Bid/Ask
45,450.00 / 45,500.00
Prev. Close
46,050
Open
45,750
Day's Range
45,400-46,200
52 wk Range
35,800-61,500
Volume
76.47K
Average Volume (3m)
144.07K
1-Year Change
-17.54%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
302440 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
38,000
Downside
-16.39%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

SK Bioscience Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

SK Bioscience Co Ltd Company Profile

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.

Employees
984

Compare 302440 to Peers and Sector

Metrics to compare
302440
Peers
Sector
Relationship
P/E Ratio
−75.8x−10.0x−0.5x
PEG Ratio
0.24−0.060.00
Price/Book
2.0x3.0x2.6x
Price / LTM Sales
9.0x28.8x3.3x
Upside (Analyst Target)
−16.4%18.4%43.4%
Fair Value Upside
Unlock7.4%7.1%Unlock

Analyst Ratings

0 Buy
3 Hold
3 Sell
Ratings:
6 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 38,000
(-16.39% Downside)

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
-199.73 / -323.89
Revenue / Forecast
131.00B / 143.00B
EPS Revisions
Last 90 days

302440 Income Statement

People Also Watch

174,100
068270
+0.93%
135,400
267250
-0.95%
30,400
009830
+0.66%
101,900
000270
+0.10%
99,600
326030
0.00%

FAQ

What Stock Exchange Does SK Bioscience Co Trade On?

SK Bioscience Co is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for SK Bioscience Co?

The stock symbol for SK Bioscience Co is "302440."

What Is the SK Bioscience Co Market Cap?

As of today, SK Bioscience Co market cap is 3.61T.

What Is SK Bioscience Co's Earnings Per Share (TTM)?

The SK Bioscience Co EPS (TTM) is -613.92.

When Is the Next SK Bioscience Co Earnings Date?

SK Bioscience Co will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is 302440 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has SK Bioscience Co Stock Split?

SK Bioscience Co has split 0 times.

How Many Employees Does SK Bioscience Co Have?

SK Bioscience Co has 984 employees.

What is the current trading status of SK Bioscience Co (302440)?

As of 08 Aug 2025, SK Bioscience Co (302440) is trading at a price of 45,450.00, with a previous close of 46,050.00. The stock has fluctuated within a day range of 45,400.00 to 46,200.00, while its 52-week range spans from 35,800.00 to 61,500.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.